4. 3 og 4. 5) samtidigt med bosentan, men der er kun begrænsede data herom til rådighed.
Liver dysfunction risk may also be increased when medicinal products that are inhibitors of the bile salt export pump (BSEP), e. g., rifampicin, glibenclamide and cyclosporine A (see sections 4.3 and 4.5), are co- administered with bosentan, but limited data are available.